United States Electrophysiology Industry Transforming to AI & Robotics | Market Trends and Future Prospects 2025-2033

"Global Electrophysiology Market reached US$9.06 Billion in 2024 and is expected to reach US$22.63 Billion by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033, according to DataM Intelligence report.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/electrophysiology-market?oppratik

United States: Recent Industry Developments:

✅ September 2025: Boston Scientific expanded the indication of its Farawave and Farawave Nav pulsed field ablation catheters for treating drug-refractory persistent atrial fibrillation with FDA approval in the US.

✅ October 2025: Abbott received FDA clearance for its AdvisorTM HD Grid X Mapping Catheter, Sensor EnabledTM, supporting advanced mapping for pulsed field and radiofrequency ablation procedures in the US.

Japan: Recent Industry Developments:

✅ August 2025: Medtronic launched its enhanced EP mapping platform in Europe and the Asia-Pacific regions, including Japan, improving access to advanced diagnostics and ablation technologies.

✅ September 2025: Japan witnessed increased adoption of pulsed field ablation (PFA) devices, with major players like Johnson & Johnson and Abbott introducing advanced cardiac mapping and ablation systems.

Mergers & Acquisitions (M&A);

-March 2025: Boston Scientific announced an agreement to acquire SoniVie Ltd., the developer of the TIVUS ultrasound-based renal denervation system, in a deal valued at approximately $600 million including milestones.

-January 2024: CardioFocus acquired the electrophysiology technology division from Galvanize Therapeutics, including the CENTAURI pulsed electric field generator system with CE marking for use in Europe.

Latest Investments:

-Early 2025: Boston Scientific continued heavy R&D investment in its Farapulse Pulsed Field Ablation (PFA) system, driving strong sales growth.

-2025: Abbott expanded clinical trials and secured regulatory clearances for new electrophysiology mapping catheters, accelerating market presence

Key Players:

Biosense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic, Boston Scientific Corporation, Siemens Healthineers AG, GE, HealthCare, Philips Healthcare, Acutus Medical, Inc, Stereotaxis, Inc, and MicroPort Scientific Corporation among others

Research Process:

Both primary and secondary data sources have been used in the global Electrophysiology Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=electrophysiology-market?oppratik

DataM Intelligence has published a new research report on "Electrophysiology Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Market Segments:

By Product Type- EP Ablation Catheters, EP Diagnostic Catheters, EP Laboratory Devices, Access Devices, Others

By Indication- Atrial Fibrillation (AF), Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia (AVNRT), Ventricular Tachycardia, Others

By End User- Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Diagnostic Centers

Latest Industry News:

✅ October 2025: The global electrophysiology market was valued at approximately $12.55 billion in 2025 and is projected to grow at a CAGR of about 11.6% to reach close to $21.72 billion by 2030, driven by rising prevalence of cardiac arrhythmias and bed-side minimally invasive treatment adoption.

✅ September 2025: Johnson & Johnson paused US sales of its Varipulse PFA system due to safety concerns, leaving Boston Scientific and Medtronic to capture market share momentum.

✅ August 2025: Abbott received CE Mark approval for its Volt PFA system achieving high success rates in European clinical trials.

✅ July 2025: Advanced technologies like AI-enhanced mapping and robotic-assisted EP platforms are being increasingly integrated into electrophysiology treatment labs, enhancing procedural efficiency and outcomes.

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/electrophysiology-market?oppratik

FDA Approval-

✅ October 2025: Abbott's AdvisorTM HD Grid X Mapping Catheter, Sensor EnabledTM received FDA clearance for advanced cardiac mapping in ablation procedures.

✅ September 2025: FDA expanded Boston Scientific's Farawave and Farawave Nav pulsed field ablation catheters' indication to include persistent atrial fibrillation treatment.

✅ July 2025: FDA granted Breakthrough Device designation to a next-gen electrophysiology catheter system aimed at improving procedure time and safety.

Key Developments:-

In December 2024, Havasu Regional Medical Center, a LifePoint hospital, launched an electrophysiology program to diagnose and treat heart arrhythmia. The program aims to improve patient outcomes and reduce the stress and financial burden associated with traveling for care. Arrhythmias, which occur when the heart beats too slowly, too fast, or irregularly, affect around 9.5 million people in the US. AFib, the most common type, has a five-fold higher stroke risk in those with AFib compared to those without it.

In October 2024, KIMSHEALTH Trivandrum inaugurated a state-of-the-art Electrophysiology Lab with advanced 3D mapping technology, inaugurated by Dr. S Somanath, Chairman of ISRO.

FAQ's:

Q1: What is the current size of the Electrophysiology Market ?

A: The Graphite Market stood at US$9.06 Billion in 2024 and is set to experience remarkable growth, reaching US$22.63 Billion by 2033

Q2: How fast is the Electrophysiology Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 10.7% from 2025 to 2033

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?oppratik

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us-

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.